Magnet Ventures

LiliumX discovers new bispecific antibodies against cancer by utilizing a protein technology platform to facilitate the scalable discovery of first-in-class bispecific biologics.

Atom Bioworks focuses on developing a pattern-recognition enabled platform that combines DNA, antibody mimics, and advanced computational techniques for the detection and treatment of infectious diseases and cancer. The platform utilizes computational biology, quantum chemistry, software, and machine learning to identify specific surface protein patterns associated with diseases. By creating corresponding pattern-matching constructs, Atom Bioworks aims to enhance researchers' capabilities in early diagnosis and therapeutic interventions, ultimately improving medical applications in the fight against infectious diseases and cancer.

Regard is a healthcare technology company that offers an intelligent platform aimed at enhancing hospital operations and patient outcomes. Utilizing artificial intelligence, the platform analyzes medical records to extract relevant information, aiding in the diagnosis of key conditions and generating accurate documentation. This approach not only streamlines administrative tasks but also enhances patient safety and physician satisfaction. By reducing coding queries and minimizing the need for extensive administrative support, Regard empowers healthcare providers to focus more on patient care while optimizing financial outcomes for hospitals.

Flux Bioscience is a company that originated from Stanford University, focusing on innovative point-of-care in vitro medical diagnostics. It has developed a portable biosensor platform designed to deliver medical-grade diagnostics directly to patients' homes. Utilizing a technology initially designed for reading and writing computer hard drives, Flux's platform analyzes blood, urine, or saliva samples to measure various biomarkers related to exercise, stress, fertility, and diet. These measurements are correlated with sleep and activity data obtained from wearable technologies. The biosensors are equipped with biochips that can detect multiple biomarkers simultaneously, providing accurate and sensitive real-time results through antibody-antigen interactions with magnetic nanoparticles. This approach empowers individuals to take charge of their healthcare and make informed lifestyle decisions.

Flux Bioscience is a company that originated from Stanford University, focusing on innovative point-of-care in vitro medical diagnostics. It has developed a portable biosensor platform designed to deliver medical-grade diagnostics directly to patients' homes. Utilizing a technology initially designed for reading and writing computer hard drives, Flux's platform analyzes blood, urine, or saliva samples to measure various biomarkers related to exercise, stress, fertility, and diet. These measurements are correlated with sleep and activity data obtained from wearable technologies. The biosensors are equipped with biochips that can detect multiple biomarkers simultaneously, providing accurate and sensitive real-time results through antibody-antigen interactions with magnetic nanoparticles. This approach empowers individuals to take charge of their healthcare and make informed lifestyle decisions.